Search Results - "Khamashta, MA"

Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients by Cervera, Ricard, Khamashta, Munther A, Font, Josep, Sebastiani, Gian Domenico, Gil, Antonio, Lavilla, Paz, Mejía, Juan Carlos, Aydintug, A Olcay, Chwalinska-Sadowska, Hanna, de Ramón, Enrique, Fernández-Nebro, Antonio, Galeazzi, Mauro, Valen, Merete, Mathieu, Alessandro, Houssiau, Frédéric, Caro, Natividad, Alba, Paula, Ramos-Casals, Manuel, Ingelmo, Miguel, Hughes, Graham R V

“…In the present study, we assessed the frequency and characteristics of the main causes of morbidity and mortality in systemic lupus erythematosus (SLE) during…”
Get full text

Treatment of menorrhagia associated with oral anticoagulation: efficacy and safety of the levonorgestrel releasing intrauterine device (Mirena coil) by Pisoni, C N, Cuadrado, M J, Khamashta, M A, Hunt, B J

“…Menorrhagia is common in women receiving oral anticoagulation. In healthy women, reductions of up to 90% of menstrual loss have been described with the…”
Get full text

The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome by Khamashta, Munther A, Cuadrado, Maria Jose, Mujic, Fedza, Taub, Nick A, Hunt, Beverley J, Hughes, Graham R.V

“…The antiphospholipid-antibody syndrome is a thrombophilic disorder in which venous or arterial thrombosis, or both, may occur. 1 The serologic markers of the…”
Get full text

Thalidomide for the treatment of resistant cutaneous lupus: efficacy and safety of different therapeutic regimens by Cuadrado, Maria J, Karim, Yousuf, Sanna, Giovanni, Smith, Elaine, Khamashta, Munther A, Hughes, Graham R V

“…Thalidomide is effective for the treatment of severe cutaneous lupus. Our aim was to study the safety and efficacy of different doses of thalidomide in this…”
Get more information

The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe by Cervera, R, Boffa, M-C, Khamashta, MA, Hughes, GRV

“…The Euro-Phospholipid project started in 1999 with a multicentre, consecutive and prospective design. A total cohort of 1000 patients with antiphospholipid…”
Get full text

Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines by Asherson, R A, Cervera, R, de Groot, P G, Erkan, D, Boffa, M-C, Piette, J-C, Khamashta, M A, Shoenfeld, Y

“…The term ‘catastrophic’ antiphospholipid syndrome (APS) is used to define an accelerated form of APS resulting in multiorgan failure. Although catastrophicAPS…”
Get full text

Skin manifestations of systemic lupus erythematosus refractory to multiple treatment modalities: poor results with mycophenolate mofetil by Pisoni, C N, Obermoser, G, Cuadrado, M J, Sanchez, F J, Karim, Y, Sepp, N T, Khamashta, M A, Hughes, G R V

“…Skin disease can be one of the most refractory clinical manifestations of systemic lupus erythematosus (SLE). The standard therapy consists of sunscreens,…”
Get full text

Primary Prevention of Thrombosis in Subjects with Positive Antiphospholipid Antibodies by Khamashta, Munther A

“…A major cause of stroke, as well as other arterial and venous thromboembolic disease has been identified—the presence of antiphospholipid antibodies (aPL). Now…”
Get full text

EULAR recommendations for the management of antiphospholipid syndrome in adults by Tektonidou, Maria G, Andreoli, Laura, Limper, Marteen, Amoura, Zahir, Cervera, Ricard, Costedoat-Chalumeau, Nathalie, Cuadrado, Maria Jose, Dörner, Thomas, Ferrer-Oliveras, Raquel, Hambly, Karen, Khamashta, Munther A, King, Judith, Marchiori, Francesca, Meroni, Pier Luigi, Mosca, Marta, Pengo, Vittorio, Raio, Luigi, Ruiz-Irastorza, Guillermo, Shoenfeld, Yehuda, Stojanovich, Ljudmila, Svenungsson, Elisabet, Wahl, Denis, Tincani, Angela, Ward, Michael M

“…The objective was to develop evidence-based recommendations for the management of antiphospholipid syndrome (APS) in adults. Based on evidence from a…”
Get more information

Antiphospholipid syndrome by Ruiz-Irastorza, Guillermo, Dr, Prof, Crowther, Mark, Prof, Branch, Ware, Prof, Khamashta, Munther A, FRCP

“…Summary The antiphospholipid syndrome causes venous, arterial, and small-vessel thrombosis; pregnancy loss; and preterm delivery for patients with severe…”
Get full text

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus by Petri, Michelle, Orbai, Ana-Maria, Alarcón, Graciela S., Gordon, Caroline, Merrill, Joan T., Fortin, Paul R., Bruce, Ian N., Isenberg, David, Wallace, Daniel J., Nived, Ola, Sturfelt, Gunnar, Ramsey-Goldman, Rosalind, Bae, Sang-Cheol, Hanly, John G., Sánchez-Guerrero, Jorge, Clarke, Ann, Aranow, Cynthia, Manzi, Susan, Urowitz, Murray, Gladman, Dafna, Kalunian, Kenneth, Costner, Melissa, Werth, Victoria P., Zoma, Asad, Bernatsky, Sasha, Ruiz-Irastorza, Guillermo, Khamashta, Munther A., Jacobsen, Soren, Buyon, Jill P., Maddison, Peter, Dooley, Mary Anne, van Vollenhoven, Ronald F., Ginzler, Ellen, Stoll, Thomas, Peschken, Christine, Jorizzo, Joseph L., Callen, Jeffrey P., Lim, S. Sam, Fessler, Barri J., Inanc, Murat, Kamen, Diane L., Rahman, Anisur, Steinsson, Kristjan, Franks Jr, Andrew G., Sigler, Lisa, Hameed, Suhail, Fang, Hong, Pham, Ngoc, Brey, Robin, Weisman, Michael H., McGwin Jr, Gerald, Magder, Laurence S.

“…Objective The Systemic Lupus International Collaborating Clinics (SLICC) group revised and validated the American College of Rheumatology (ACR) systemic lupus…”
Get full text

Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort by Bruce, Ian N, O'Keeffe, Aidan G, Farewell, Vern, Hanly, John G, Manzi, Susan, Su, Li, Gladman, Dafna D, Bae, Sang-Cheol, Sanchez-Guerrero, Jorge, Romero-Diaz, Juanita, Gordon, Caroline, Wallace, Daniel J, Clarke, Ann E, Bernatsky, Sasha, Ginzler, Ellen M, Isenberg, David A, Rahman, Anisur, Merrill, Joan T, Alarcón, Graciela S, Fessler, Barri J, Fortin, Paul R, Petri, Michelle, Steinsson, Kristjan, Dooley, Mary Anne, Khamashta, Munther A, Ramsey-Goldman, Rosalind, Zoma, Asad A, Sturfelt, Gunnar K, Nived, Ola, Aranow, Cynthia, Mackay, Meggan, Ramos-Casals, Manuel, van Vollenhoven, Ronald F, Kalunian, Kenneth C, Ruiz-Irastorza, Guillermo, Lim, Sam, Kamen, Diane L, Peschken, Christine A, Inanc, Murat, Urowitz, Murray B

“…We studied damage accrual and factors determining development and progression of damage in an international cohort of systemic lupus erythematosus (SLE)…”
Get more information

Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report by Lockshin, M, Tenedios, F, Petri, M, McCarty, G, Forastiero, R, Krilis, S, Tincani, A, Erkan, D, Khamashta, M A, Shoenfeld, Y

“…The Committee reviewed cardiac involvement in the antiphospholipid antibody syndrome. The Committee’s recommendations are: Valve abnormalities: anticoagulation…”
Get full text

Laboratory diagnosis and management challenges in the antiphospholipid syndrome by Bertolaccini, M L, Khamashta, M A

“…The antiphospholipid syndrome (APS) is characterized by recurrent arterial and/or venous thrombosis and pregnancy morbidity manifested by early or late losses…”
Get full text

Update on therapy — thalidomide in the treatment of lupus by Karim, M Y, Ruiz-Irastorza, G, Khamashta, M A, Hughes, G RV

“…Thalidomide has been shown to be an effective treatment for cutaneous forms of lupus erythematous refractory to other therapies. Thalidomide has very serious…”
Get full text

Systemic lupus erythematosus by D'Cruz, David P, Dr, Khamashta, Munther A, FRCP, Hughes, Graham RV, FRCP

“…Summary Systemic lupus erythematosus is an autoimmune connective-tissue disorder with a wide range of clinical features, which predominantly affects women,…”
Get full text

Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies by Chapman, J, Rand, J H, Brey, R L, Levine, S R, Blatt, I, Khamashta, M A, Shoenfeld, Y

“…Although many types of neurological disorders and events have been described in association with antiphospholipidantibodies(aPL) and the…”
Get full text

Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes by Khamashta, M A, Harris, E N, Gharavi, A E, Derue, G, Gil, A, Vázquez, J J, Hughes, G R

“…Because thrombocytopenia occurs frequently in patients with anticardiolipin (aCL) antibodies and thrombosis, some investigators have proposed that aCL…”
Get full text

European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies by Mosca, M, Tani, C, Aringer, M, Bombardieri, S, Boumpas, D, Brey, R, Cervera, R, Doria, A, Jayne, D, Khamashta, M A, Kuhn, A, Gordon, C, Petri, M, Rekvig, O P, Schneider, M, Sherer, Y, Shoenfeld, Y, Smolen, J S, Talarico, R, Tincani, A, van Vollenhoven, R F, Ward, M M, Werth, V P, Carmona, L

“…To develop recommendations for monitoring patients with systemic lupus erythematosus (SLE) in clinical practice and observational studies and to develop a…”
Get more information

Clinical accuracy for diagnosis of antiphospholipid syndrome in systemic lupus erythematosus: evaluation of 23 possible combinations of antiphospholipid antibody specificities by SCIASCIA, S., MURRU, V., SANNA, G., ROCCATELLO, D., KHAMASHTA, M. A., BERTOLACCINI, M. L.

“…Objectives: To evaluate the clinical accuracy of antiphospholipid antibody (aPL) specificities both individually and/or in combination, in a wide cohort of…”
Get full text